Change Language
English - Change Language
Recent Updates
  • The at-home self-testing kits market is projected to grow at a healthy pace, till 2035, claims Roots Analysis Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes. For additional details, please visit https://www.rootsanalysis.com/reports/self-testing-kits-market.html
    The at-home self-testing kits market is projected to grow at a healthy pace, till 2035, claims Roots Analysis Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes. For additional details, please visit https://www.rootsanalysis.com/reports/self-testing-kits-market.html
    WWW.ROOTSANALYSIS.COM
    At-home Self Testing Kits Market | Market Size | Industry Analysis | 2035
    Owing to rising demand for infectious disease kits and 500+ marketed / under development self-testing kits, at-home self testing kits market is anticipated to witness a rapid growth in the coming years
    0 Comments 0 Shares
  • THE PHARMACEUTICAL INDUSTRY IS PRESENTLY EXPERIENCING A PROMINENT NEED FOR BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES AND SERVICES Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html
    THE PHARMACEUTICAL INDUSTRY IS PRESENTLY EXPERIENCING A PROMINENT NEED FOR BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES AND SERVICES Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html
    WWW.ROOTSANALYSIS.COM
    Bioavailability Enhancement Technologies and Services | Market Size | 2035
    The space of bioavailability enhancement technologies and services, driven by the increase in number of BCS II and BCS IV molecules in early phases of development, is likely to grow at CAGR of ~11%, till 2035
    0 Comments 0 Shares
  • The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share For additional details, please visit https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html
    The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share For additional details, please visit https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html
    WWW.ROOTSANALYSIS.COM
    SARM1 Inhibitors Market | Industry Analysis | Market Size | 2040
    SARM1 Inhibitors market, driven by active research and growing pipeline, is anticipated to grow at over 100% CAGR after first approval in 2033
    0 Comments 0 Shares
  • The cell and gene therapy CROs market is anticipated to grow at an annualized rate of 18% by 2035, claims Roots Analysis Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
    The cell and gene therapy CROs market is anticipated to grow at an annualized rate of 18% by 2035, claims Roots Analysis Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
    WWW.ROOTSANALYSIS.COM
    Cell and Gene Therapy CRO | Industry Analysis | Market Size | 2035
    Driven by rapid interest in cell and gene therapies (evident from over 3500 ATMPs being investigated), the cell and gene therapy CRO market is anticipated to grow at over 18% CAGR
    0 Comments 0 Shares
  • THE MRNA THERAPEUTICS AND VACCINES SEGMENT IS ANTICIPATED TO REVOLUTIONIZE THE BIOPHARMACEUTICAL INDUSTRY Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic disorders and other disorders. For additional details, please visit https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html
    THE MRNA THERAPEUTICS AND VACCINES SEGMENT IS ANTICIPATED TO REVOLUTIONIZE THE BIOPHARMACEUTICAL INDUSTRY Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic disorders and other disorders. For additional details, please visit https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html
    WWW.ROOTSANALYSIS.COM
    mRNA Therapeutics and mRNA Vaccines Market | Industry Analysis | Market Size | 2035
    With over 35 players engaged in development of mRNA therapeutics and mRNA vaccines, and nearly USD 11 billion funding by investors, the market is anticipated to grow rapidly in the coming years
    0 Comments 0 Shares
  • The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime focus being oncology, to enable the treatment of several prevalent malignancies. For additional details, please visit https://www.rootsanalysis.com/reports/ai-in-oncology-market.html
    The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime focus being oncology, to enable the treatment of several prevalent malignancies. For additional details, please visit https://www.rootsanalysis.com/reports/ai-in-oncology-market.html
    WWW.ROOTSANALYSIS.COM
    Artificial Intelligence In Oncology Market | Market Size | 2035
    Artificial Intelligence In Oncology / AI in Oncology Market is anticipated to grow at over 50% CAGR driven by nearly USD 6 billion investment in the recent years
    0 Comments 0 Shares
  • The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% till 2035, claims Roots Analysis Rise in clinical research activity for genetically modified therapies has resulted in the increase in demand for vectors, offering lucrative opportunities to players having capabilities for in-house and contract manufacturing of various types of vectors. For additional details, please visit link https://www.rootsanalysis.com/reports/view_document/viral-vectors-non-viral-vectors-and-gene-therapy-manufacturing-market-/274.html
    The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% till 2035, claims Roots Analysis Rise in clinical research activity for genetically modified therapies has resulted in the increase in demand for vectors, offering lucrative opportunities to players having capabilities for in-house and contract manufacturing of various types of vectors. For additional details, please visit link https://www.rootsanalysis.com/reports/view_document/viral-vectors-non-viral-vectors-and-gene-therapy-manufacturing-market-/274.html
    WWW.ROOTSANALYSIS.COM
    Viral Vectors Manufacturing and Gene Therapy Manufacturing | Market Size | 2035
    The viral vector and gene therapy market, is projected to be worth more than USD 2 Billion by 2035 Growing at an Annualized Rate of Over 20%
    0 Comments 0 Shares
  • SEVERAL PHARMACEUTICAL COMPANIES HAVE DEMONSTRATED A PREFERENCE TO OUTSOURCE THEIR PATIENT RECRUITMENT OPERATIONS Clinical trials form an essential part of the overall drug development process, evaluating the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials. For additional details, please visit link https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html
    SEVERAL PHARMACEUTICAL COMPANIES HAVE DEMONSTRATED A PREFERENCE TO OUTSOURCE THEIR PATIENT RECRUITMENT OPERATIONS Clinical trials form an essential part of the overall drug development process, evaluating the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials. For additional details, please visit link https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html
    WWW.ROOTSANALYSIS.COM
    Patient Recruitment and Patient Retention Services Market | Industry Analysis | 2035
    Given the active involement of close to 140 players, the patient recruitment services market is anticipated to grow at an annualized rate of ~4% till 2035...
    0 Comments 0 Shares
  • The ADC contract manufacturing market is projected to grow at a CAGR of more than 13% till 2035 Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initiatives to become one-stop-shops to cater to the diverse needs of ADC developers. For additional details please visit https://www.rootsanalysis.com/reports/view_document/adc-contract-manufacturing-market/218.html
    The ADC contract manufacturing market is projected to grow at a CAGR of more than 13% till 2035 Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initiatives to become one-stop-shops to cater to the diverse needs of ADC developers. For additional details please visit https://www.rootsanalysis.com/reports/view_document/adc-contract-manufacturing-market/218.html
    WWW.ROOTSANALYSIS.COM
    ADC Contract Manufacturing Market | Industry Analysis | Market Size | 2035
    Overall, we expect the ADC contract manufacturing market to grow at an annualized rate of over 12%, during the period 2022-2035
    0 Comments 0 Shares
  • The taste masking market is anticipated to grow at a steady pace till 2035, claims Roots Analysis Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment technologies is expected to rise in the coming years. For additional details, please visit https://www.rootsanalysis.com/reports/taste-masking-services-market.html
    The taste masking market is anticipated to grow at a steady pace till 2035, claims Roots Analysis Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment technologies is expected to rise in the coming years. For additional details, please visit https://www.rootsanalysis.com/reports/taste-masking-services-market.html
    WWW.ROOTSANALYSIS.COM
    Taste Masking and Taste Assessment | Industry Analysis | Market Size | 2035
    Taste Masking and Taste Assessment Service and Technology Market report features a detailed study of the current scenario and future potential of the DNA synthesis...
    0 Comments 0 Shares
More Stories